[go: up one dir, main page]

DE60015559D1 - Sentrin-spezifische menschliche protease senp1 - Google Patents

Sentrin-spezifische menschliche protease senp1

Info

Publication number
DE60015559D1
DE60015559D1 DE60015559T DE60015559T DE60015559D1 DE 60015559 D1 DE60015559 D1 DE 60015559D1 DE 60015559 T DE60015559 T DE 60015559T DE 60015559 T DE60015559 T DE 60015559T DE 60015559 D1 DE60015559 D1 DE 60015559D1
Authority
DE
Germany
Prior art keywords
senp1
sentrin
specific human
human protease
sequences
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60015559T
Other languages
English (en)
Other versions
DE60015559T2 (de
Inventor
Edward T H Yeh
Limin Gong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
University of Texas at Austin
Original Assignee
University of Texas System
University of Texas at Austin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Texas System, University of Texas at Austin filed Critical University of Texas System
Application granted granted Critical
Publication of DE60015559D1 publication Critical patent/DE60015559D1/de
Publication of DE60015559T2 publication Critical patent/DE60015559T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60015559T 1999-07-31 2000-07-31 Sentrin-spezifische menschliche protease senp1 Expired - Fee Related DE60015559T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14677499P 1999-07-31 1999-07-31
US146774P 1999-07-31
PCT/US2000/020884 WO2001009292A2 (en) 1999-07-31 2000-07-31 Sentrin-specific human proteases senp1-3

Publications (2)

Publication Number Publication Date
DE60015559D1 true DE60015559D1 (de) 2004-12-09
DE60015559T2 DE60015559T2 (de) 2005-10-27

Family

ID=22518951

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60015559T Expired - Fee Related DE60015559T2 (de) 1999-07-31 2000-07-31 Sentrin-spezifische menschliche protease senp1

Country Status (7)

Country Link
US (2) US6596527B1 (de)
EP (1) EP1204746B1 (de)
JP (1) JP2003506032A (de)
AT (1) ATE281522T1 (de)
CA (1) CA2387655A1 (de)
DE (1) DE60015559T2 (de)
WO (1) WO2001009292A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001009292A2 (en) * 1999-07-31 2001-02-08 Board Of Regents, The University Of Texas System Sentrin-specific human proteases senp1-3
GB0028761D0 (en) * 2000-11-24 2001-01-10 Glaxo Group Ltd New protein
AU2003209105A1 (en) * 2002-02-08 2003-09-02 Applera Corporation Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
US7939251B2 (en) 2004-05-06 2011-05-10 Roche Molecular Systems, Inc. SENP1 as a marker for cancer
WO2006073976A2 (en) * 2004-12-30 2006-07-13 Lifesensors, Inc. Compositions, methods, and kits for enhancing protein expression, solubility and isolation

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0960126A4 (de) 1996-11-05 2004-05-19 Univ Texas Zusammensetzungen und Verwendung von Sentrin, einem Zelltod schützenden Protein
GB9712415D0 (en) 1997-06-13 1997-08-13 Innes John Centre Innov Ltd Genetic control of flowering
US6222029B1 (en) * 1997-08-01 2001-04-24 Genset 5′ ESTs for secreted proteins expressed in brain
US20020106373A1 (en) * 1998-04-29 2002-08-08 Incyte Pharmaceuticals, Inc. Proteins associated with EGF signaling
WO2000078934A2 (en) * 1999-06-22 2000-12-28 School Of Pharmacy, University Of London Use of the ubiquitin specific protease usp25 in the diagnosis and treatment of alzheimer's disease
WO2001009292A2 (en) * 1999-07-31 2001-02-08 Board Of Regents, The University Of Texas System Sentrin-specific human proteases senp1-3
GB0027905D0 (en) * 2000-11-15 2000-12-27 Glaxo Group Ltd New protein
EP1392733A4 (de) * 2001-01-19 2004-06-23 Univ Leland Stanford Junior Tumorsuszeptibilitätsgenprodukte aus säugern und deren verwendungen
WO2002090495A2 (en) * 2001-05-04 2002-11-14 Cornell Research Foundation, Inc. Rapidly cleavable sumo fusion protein expression system for difficult to express proteins
US7579152B2 (en) * 2004-08-27 2009-08-25 Board Of Regents, The University Of Texas System SENP1 as a marker of cancer development and target for cancer therapy

Also Published As

Publication number Publication date
WO2001009292A2 (en) 2001-02-08
EP1204746B1 (de) 2004-11-03
WO2001009292A3 (en) 2001-08-16
ATE281522T1 (de) 2004-11-15
JP2003506032A (ja) 2003-02-18
US7588927B2 (en) 2009-09-15
US6596527B1 (en) 2003-07-22
US20060134741A1 (en) 2006-06-22
DE60015559T2 (de) 2005-10-27
CA2387655A1 (en) 2001-02-08
EP1204746A2 (de) 2002-05-15

Similar Documents

Publication Publication Date Title
ATE500323T1 (de) Subtilisin-variante
PT1178958E (pt) N-cianometilamidas como inibidores de proteases
DK1162995T3 (da) Enzymer til behandling af diabetes mellitus type I
YU9404A (sh) Multimerna, usmerena kontrastna sredstva na bazi peptida
SE0201980D0 (sv) Novel compounds
WO2002000860A3 (en) Novel proteases
BRPI0510527A (pt) método de estabilização de proteìnas
DK1349944T3 (da) Latensassocieret peptid af TGF-beta til at bibringe farmaceutisk aktive proteiner latens
SE0002202D0 (sv) New peptides
EP0975353A4 (de) Peptidyl-2-amino-1hydroxyalkansulfonsäuren als cystein-protease-inhibitoren
SE0201977D0 (sv) Novel compounds
YU68702A (sh) Novi lhrh-antagonisti, njihova proizvodnja i upotreba kao leka
CY1113871T1 (el) Διαδικασια παρασκευης γκαμπαπεντινης
MXPA05008240A (es) Inhibidores de catepsina s.
SE0203712D0 (sv) Novel compounds
ATE281522T1 (de) Sentrin-spezifische menschliche protease senp1
WO2000001826A3 (en) Stabilized variants of streptomyces subtilisin inhibitor
DE60332425D1 (de) 5t4-antigen-peptidepitope der mhc klasse ii
DE50110723D1 (de) Isolierte luziferasen sowie deren verwendung
AU6011001A (en) Novel lhrh-antagonists, production and use thereof as medicament
ATE533779T1 (de) Isoliertes photoprotein mtclytin, sowie dessen verwendung
WO2004053117A3 (en) Serine protease
WO2003082897A3 (en) Synthetic active peptide fragments
AR016514A1 (es) Composicion para mejorar el malestar estomacal, metodo para preparar dicha composicion y metodo para utilizarla
NO20053575D0 (no) Metallprotease proteiner

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee